gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember
2024-01-01
2024-03-31
0001551152
us-gaap:InterestRateSwapMember
us-gaap:DesignatedAsHedgingInstrumentMember
2024-01-01
2024-03-31
0001551152
abbv:NiaspanMember
2025-01-01
2025-03-31
0001551152
abbv:PrescriptionDrugAbuseLitigationMember
2025-03-31
0001551152
abbv:PrescriptionDrugAbuseLitigationInStateCourtsMember
2025-03-31
0001551152
abbv:PrescriptionDrugAbuseLitigationBroughtByStatesCountiesCitiesAndOtherMunicipalEntitiesMember
2025-03-31
0001551152
abbv:PrescriptionDrugAbuseLitigationInStateCourtsInProcessOfBeingDismissedMember
2025-03-31
0001551152
abbv:PrescriptionDrugAbuseLitigationCoveredByAProposedClassSettlementMember
2025-03-31
0001551152
abbv:TaxCourtPetitionMember
2023-03-01
2023-03-31
0001551152
abbv:ProductLiabilityALCLLitigationMember
2025-03-31
0001551152
abbv:ProductLiabilityOtherLitigationMember
2025-03-31
0001551152
abbv:ProductLiabilityALCLLitigationInStateCourtMember
2025-03-31
0001551152
abbv:ProductLiabilityOtherLitigationInStateCourtMember
2025-03-31
0001551152
abbv:ProductLiabilityALCLLitigationInOtherCountriesMember
2025-03-31
0001551152
abbv:ProductLiabilityOtherLitigationInOtherCountriesMember
2025-03-31
0001551152
country:US
abbv:ImmunologyMember
abbv:SKYRIZIMember
2025-01-01
2025-03-31
0001551152
country:US
abbv:ImmunologyMember
abbv:SKYRIZIMember
2024-01-01
2024-03-31
0001551152
us-gaap:NonUsMember
abbv:ImmunologyMember
abbv:SKYRIZIMember
2025-01-01
2025-03-31
0001551152
us-gaap:NonUsMember
abbv:ImmunologyMember
abbv:SKYRIZIMember
2024-01-01
2024-03-31
0001551152
abbv:ImmunologyMember
abbv:SKYRIZIMember
2025-01-01
2025-03-31
0001551152
abbv:ImmunologyMember
abbv:SKYRIZIMember
2024-01-01
2024-03-31
0001551152
country:US
abbv:ImmunologyMember
abbv:RINVOQMember
2025-01-01
2025-03-31
0001551152
country:US
abbv:ImmunologyMember
abbv:RINVOQMember
2024-01-01
2024-03-31
0001551152
us-gaap:NonUsMember
abbv:ImmunologyMember
abbv:RINVOQMember
2025-01-01
2025-03-31
0001551152
us-gaap:NonUsMember
abbv:ImmunologyMember
abbv:RINVOQMember
2024-01-01
2024-03-31
0001551152
abbv:ImmunologyMember
abbv:RINVOQMember
2025-01-01
2025-03-31
0001551152
abbv:ImmunologyMember
abbv:RINVOQMember
2024-01-01
2024-03-31
0001551152
country:US
abbv:ImmunologyMember
abbv:HUMIRAMember
2025-01-01
2025-03-31
0001551152
country:US
abbv:ImmunologyMember
abbv:HUMIRAMember
2024-01-01
2024-03-31
0001551152
us-gaap:NonUsMember
abbv:ImmunologyMember
abbv:HUMIRAMember
2025-01-01
2025-03-31
0001551152
us-gaap:NonUsMember
abbv:ImmunologyMember
abbv:HUMIRAMember
2024-01-01
2024-03-31
0001551152
abbv:ImmunologyMember
abbv:HUMIRAMember
2025-01-01
2025-03-31
0001551152
abbv:ImmunologyMember
abbv:HUMIRAMember
2024-01-01
2024-03-31
0001551152
country:US
abbv:NeuroscienceMember
abbv:VraylarMember
2025-01-01
2025-03-31
0001551152
country:US
abbv:NeuroscienceMember
abbv:VraylarMember
2024-01-01
2024-03-31
0001551152
us-gaap:NonUsMember
abbv:NeuroscienceMember
abbv:VraylarMember
2025-01-01
2025-03-31